Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M104,650Revenue (TTM) $M24,754Net Margin (%)23.1Altman Z-Score2.0
Enterprise Value $M134,493EPS (TTM) $3.5Operating Margin %35.0Piotroski F-Score7
P/E(ttm)18.5Beneish M-Score-2.4Pre-tax Margin (%)30.1Higher ROA y-yY
Price/Book18.410-y EBITDA Growth Rate %--Quick Ratio1.6Cash flow > EarningsY
Price/Sales4.35-y EBITDA Growth Rate %--Current Ratio1.8Lower Leverage y-yY
Price/Free Cash Flow13.8y-y EBITDA Growth Rate %129ROA % (ttm)10.1Higher Current Ratio y-yY
Dividend Yield %3.5PEG--ROE % (ttm)116Less Shares Outstanding y-yY
Payout Ratio %62.0Shares Outstanding M1,629ROIC % (ttm)22.7Gross Margin Increase y-yN

Gurus Latest Trades with ABBV

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABBVNWQ Managers 2016-06-30 Reduce-0.2%$57.12 - $65.09
($60.87)
$ 64.266%Reduce -28.08%562,288
ABBVJoel Greenblatt 2016-06-30 Add0.19%$57.12 - $65.09
($60.87)
$ 64.266%Add 40.22%905,598
ABBVDavid Dreman 2016-06-30 Reduce-0.1%$57.12 - $65.09
($60.87)
$ 64.266%Reduce -47.95%15,897
ABBVKen Fisher 2016-06-30 Reduce-0.01%$57.12 - $65.09
($60.87)
$ 64.266%Reduce -6.71%693,394
ABBVMario Gabelli 2016-06-30 Reduce$57.12 - $65.09
($60.87)
$ 64.266%Reduce -0.46%35,296
ABBVJoel Greenblatt 2016-03-31 Add0.28%$51.18 - $59.24
($55.77)
$ 64.2615%Add 216.32%645,835
ABBVJohn Paulson 2016-03-31 Sold Out -0.05%$51.18 - $59.24
($55.77)
$ 64.2615%Sold Out0
ABBVDavid Dreman 2016-03-31 Add0.03%$51.18 - $59.24
($55.77)
$ 64.2615%Add 16.28%30,542
ABBVNWQ Managers 2016-03-31 Add0.02%$51.18 - $59.24
($55.77)
$ 64.2615%Add 3.64%781,850
ABBVKen Fisher 2016-03-31 Reduce-0.02%$51.18 - $59.24
($55.77)
$ 64.2615%Reduce -20.51%743,284
ABBVMario Gabelli 2016-03-31 Reduce$51.18 - $59.24
($55.77)
$ 64.2615%Reduce -12.66%35,460
ABBVDodge & Cox 2016-03-31 Reduce$51.18 - $59.24
($55.77)
$ 64.2615%Reduce -0.07%33,232
ABBVNWQ Managers 2015-12-31 Reduce-0.65%$48.27 - $64.13
($57.69)
$ 64.2611%Reduce -50.59%754,413
ABBVFirst Eagle Investment 2015-12-31 Sold Out -0.14%$48.27 - $64.13
($57.69)
$ 64.2611%Sold Out0
ABBVJoel Greenblatt 2015-12-31 Add0.08%$48.27 - $64.13
($57.69)
$ 64.2611%Add 179.54%204,171
ABBVJohn Paulson 2015-12-31 Buy 0.05%$48.27 - $64.13
($57.69)
$ 64.2611%New holding139,700
ABBVDavid Dreman 2015-12-31 Reduce-0.03%$48.27 - $64.13
($57.69)
$ 64.2611%Reduce -15.80%26,267
ABBVKen Fisher 2015-12-31 Add$48.27 - $64.13
($57.64)
$ 64.2611%Add 0.77%935,104
ABBVMario Gabelli 2015-12-31 Reduce$48.27 - $64.13
($57.69)
$ 64.2611%Reduce -7.58%40,600
ABBVFirst Eagle Investment 2015-09-30 Add0.05%$52.5 - $71.23
($65.09)
$ 64.26-1%Add 55.71%1,056,150
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABBV is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ABBV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Schumacher Laura JExecutive Vice President 2016-06-24Sell186,106$60.037.46view
GONZALEZ RICHARD AChairman of the Board and CEO 2016-06-02Sell285,953$63.821.08view
GONZALEZ RICHARD AChairman of the Board and CEO 2016-05-11Sell39,000$63.81.11view
HURWICH THOMAS A.VP, Controller 2016-05-10Sell6,000$63.591.45view
RICHMOND TIMOTHY J.SVP, Human Resources 2016-05-10Sell21,583$63.521.56view
ALBAN CARLOSEVP, Commercial Operations 2016-05-10Sell47,438$63.521.56view
Schumacher Laura JExecutive Vice President 2016-03-08Sell25,000$56.0915.01view
RICHMOND TIMOTHY J.SVP, Human Resources 2016-03-01Sell12,866$55.0517.18view
SALEKI-GERHARDT AZITASVP, Operations 2016-02-29Sell1,776$55.3816.49view
HURWICH THOMAS A.VP, Controller 2016-02-29Sell1,444$55.2516.76view

Press Releases about ABBV :

Quarterly/Annual Reports about ABBV:

News about ABBV:

Articles On GuruFocus.com
Healthcare Dividend Growth Stocks: Part 1 Aug 12 2016 
Healthcare Dividend Growth Stocks: Part 1 Aug 04 2016 
Eaton Vance Worldwide Health Sciences Fund 2nd Quarter Commentary Aug 04 2016 
Can Novartis Win the Entresto Bet? Aug 03 2016 
9 Best Stocks for Value Investors This Week Jul 26 2016 
An Unfair Valuation Makes a Great Investment Jul 15 2016 
These Are the Only Dividend Aristocrats I Would Consider Today Jul 07 2016 
5 Attractive Biotechnology Stocks for Healthy Long-term Returns Jun 10 2016 
Weekly CEO Sells Highlight Jun 06 2016 
Wall Street Estimates and Biopharma Value Investing Jun 02 2016 

More From Other Websites
7 Healthy Dividend Stocks for Quality and Security Aug 29 2016
[$$] The 10 Best Dividend Stocks Aug 26 2016
AbbVie Inc (ABBV) Expected To Launch Zinbryta In The US This Month Aug 26 2016
AbbVie Expects Investigational Drug Elagolix to Be a Blockbuster Aug 26 2016
Could Zinbryta Become a Novel Immunomodulatory Therapy for MS? Aug 26 2016
AbbVie Launched Zinbryta in the US in August Aug 25 2016
How Late-Stage Asset Rova-T Could Become a Leading Therapy Aug 25 2016
Major Pharma Short Interest Faces Significant Drop Aug 25 2016
How AbbVie Expects BCL-2 Inhibitor Venclexta to Prove Effective Aug 25 2016
Imbruvica Continues to Report Better-than-Expected Sales in 2016 Aug 24 2016
How Humira-Related Uncertainty Has Affected AbbVie’s Valuations Aug 24 2016
AbbVie Expects to Commercialize Selective JAK1 Inhibitor ABT-494 Aug 24 2016
How AbbVie Expects Risankizumab to Be a Transformative Therapy Aug 23 2016
What Are Analysts’ Recommendations for AbbVie in 2016? Aug 23 2016
How AbbVie’s Valuation Multiples Compare with Its Peers’ Aug 23 2016
[$$] Pfizer’s Medivation Deal Latest in Long Line of Similar Acquisitions Aug 22 2016
[$$] Pfizer's Medivation Deal Latest in Long Line of Similar Acquisitions Aug 22 2016
Can Allergan Generics Boost Teva Pharmaceutical’s 2016 Revenues? Aug 22 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)